Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nijsten

Showing results (61-70 of 701) with videos related to

Pageof 71
Sort By:
Intensive Care Medicine|May 17, 2017
The fractal lightning burn results from a positively charged strike : Discussion on "Resuscitated unconscious male: Lichtenberg's sign lighting the way"Maarten Nijsten, Andrew Lindford, Jyrki Vuola, et al.
Acta Dermato-Venereologica|May 20, 2006
Dimensionality of the dermatology life quality index (DLQI): a commentaryTamar Nijsten, David M Meads, Stephen P McKenna
Archives of Dermatology|March 17, 2004
Lymphomatoid papulosis in children: a retrospective cohort study of 35 casesTamar Nijsten, Clara Curiel-Lewandrowski, Marshall E Kadin
Journal of Cutaneous Pathology|April 7, 2005
Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursorsTamar Nijsten, Elke Geluyckens, Cecile Colpaert, et al.
Annals of Intensive Care|May 14, 2013
Clinical use of lactate monitoring in critically ill patientsJan Bakker, Maarten Wn Nijsten, Tim C Jansen
The Journal of Investigative Dermatology|October 9, 2009
Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohortMarlies Wakkee, Ron M C Herings, Tamar Nijsten
Archives of Dermatology|July 12, 2012
Chemoprevention for keratinocytic (pre)cancers: balancing the risks and benefitsLoes M Hollestein, Els R Koomen, Tamar Nijsten
Dermatology (Basel, Switzerland)|June 22, 2002
Thalidomide-induced morbilliform rash: diagnosis and continuation of therapy, premedicated with methylprednisoloneT Nijsten, L Meuleman, W Schroyens, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2012
Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008L M Hollestein, E de Vries, T Nijsten
Critical Care (London, England)|December 19, 2007
A wise nurse can manage a paper protocol but prefers intelligent technologyMathijs Vogelzang, Felix Zijlstra, Maarten W N Nijsten
Pageof 71

Showing results (61-70 of 701) with videos related to

Sort By:
Pageof 71
Intensive Care Medicine|May 17, 2017
The fractal lightning burn results from a positively charged strike : Discussion on "Resuscitated unconscious male: Lichtenberg's sign lighting the way"Maarten Nijsten, Andrew Lindford, Jyrki Vuola, et al.
Acta Dermato-Venereologica|May 20, 2006
Dimensionality of the dermatology life quality index (DLQI): a commentaryTamar Nijsten, David M Meads, Stephen P McKenna
Archives of Dermatology|March 17, 2004
Lymphomatoid papulosis in children: a retrospective cohort study of 35 casesTamar Nijsten, Clara Curiel-Lewandrowski, Marshall E Kadin
Journal of Cutaneous Pathology|April 7, 2005
Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursorsTamar Nijsten, Elke Geluyckens, Cecile Colpaert, et al.
Annals of Intensive Care|May 14, 2013
Clinical use of lactate monitoring in critically ill patientsJan Bakker, Maarten Wn Nijsten, Tim C Jansen
The Journal of Investigative Dermatology|October 9, 2009
Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohortMarlies Wakkee, Ron M C Herings, Tamar Nijsten
Archives of Dermatology|July 12, 2012
Chemoprevention for keratinocytic (pre)cancers: balancing the risks and benefitsLoes M Hollestein, Els R Koomen, Tamar Nijsten
Dermatology (Basel, Switzerland)|June 22, 2002
Thalidomide-induced morbilliform rash: diagnosis and continuation of therapy, premedicated with methylprednisoloneT Nijsten, L Meuleman, W Schroyens, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2012
Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008L M Hollestein, E de Vries, T Nijsten
Critical Care (London, England)|December 19, 2007
A wise nurse can manage a paper protocol but prefers intelligent technologyMathijs Vogelzang, Felix Zijlstra, Maarten W N Nijsten
Pageof 71